Doxycycline is a small molecule (originally an antibiotic) that is being investigated as a possible alpha-synuclein (aSyn) inhibitor. Alpha-synuclein aggregation is a hallmark of Parkinson’s disease, and by inhibiting this process, doxycycline could potentially slow the disease’s progression.
Discover our Products
Science-based and high-quality devices
